We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost ...

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...

OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.

The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...

The A.A.O. recommends that adults with no signs or risk factors for eye disease get a comprehensive exam at 40 to establish a ...

Scientists found that protein deposits in the retina create unique light patterns for different brain diseases in humans.

A 2026 company-issued report outlining Retina Clear's 'Red Root Hack' marketing narrative, ingredient research context, ...

With the number of diabetes cases surging across India, doctors warn that a silent epidemic of diabetes-related vision loss is emerging, particularly among younger adults. Lack of awareness, delayed ...

I have pushed myself way more physically and mentally as a blind man than I ever did as a sighted person,” says Torbet ...

This ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global ...

A common medication may have an unexpected effect on a serious eye condition, new research suggests.

Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, has declared March 23-29, 2026, as its first-ever Keratoconus Week. The ...